Tectonic Therapeutic | AVRO - Loan Capital


Tectonic Therapeutic reported $100K in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Alnylam Pharmaceuticals USD 1.04B 13.75M Sep/2025
Celltrion KRW 63.29B 4.01B Sep/2025
Cspc Pharmaceutical CNY 158.75M 102.62M Jun/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Ionis Pharmaceuticals USD 28.78M 596.71M Sep/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
MacroGenics USD 70.26M 4K Sep/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.67M 95K Jun/2025
Organigram Holdings CAD 76.4M 23.6M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Pharma Mar EUR 37.75M 180K Sep/2025
Qiagen NV USD 1.64B 754.35M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
Sarepta Therapeutics USD 1.04B 104.31M Sep/2025
Sartorius EUR 3.41B 682.5M Sep/2025
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Takeda JPY 4.27T 81.29B Dec/2025
Tilray USD 279.22M 18.87M Mar/2025
Zz Pientze Pharmaceu CNY 186.56M 9.75M Sep/2025